Semnur Pharmaceuticals, Inc. (SMNR)
0.55
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Semnur Pharmaceuticals EPS Diluted (Quarterly) : -0.0189 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0189 |
| March 31, 2026 | -0.0199 |
| December 31, 2025 | -0.0268 |
| September 30, 2025 | -0.7566 |
| June 30, 2025 | -0.005 |
| March 31, 2025 | -0.0033 |
| December 31, 2024 | -0.0039 |
| September 30, 2024 | -0.0065 |
| June 30, 2024 | 0.0631 |
| Date | Value |
|---|---|
| March 31, 2024 | 0.0372 |
| December 31, 2023 | 0.056 |
| September 30, 2023 | 0.0583 |
| June 30, 2023 | 0.0423 |
| March 31, 2023 | -0.0932 |
| December 31, 2022 | -0.0633 |
| September 30, 2022 | 0.0284 |
| June 30, 2022 | -0.0028 |
| March 31, 2022 | -0.001 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Scilex Holding Co. | -16.65 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.347M |
| Total Expenses (Quarterly) | 4.347M |
| Enterprise Value | 149.63M |
| Earnings Yield | -149.5% |
| Normalized Earnings Yield | -149.47 |